In HPV- HNSCC, STING expression is suppressed, and is further downregulated in AR cells; therefore, we investigated whether treatment promoting STING combined with apatinib has therapeutic potential in HNSCC. The gene discussed is STING1; the disease is head and neck squamous cell carcinoma.